Rare disease (RD) patients in Spain typically find themselves without much support, and often without a proper diagnosis. So Alexion, AstraZeneca’s rare disease division, brought RD patients’ stories to the publics attention and empowered patients to share their own Identity Diagnosis - in ways they’d never been told before.